PharmEasy's parent raises debt funding
The firm had plans to raise ₹6,250 crore via its IPO but had deferred the issue, citing market conditions and strategic considerations. At that time, the company had said that it would instead raise funds from existing shareholders via a rights issue
Source: livemint.com